New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects; D001932:Brain Neoplasms / Q000276:immunology / Q000628:therapy*; D002330:Carmustine / Q000008:administration & dosage; D005910:Glioma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007114:Immunization / Q000379:methods; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy / Q000379:methods*; D007370:Interferon Type I / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008222:Lymphokines / Q000627:therapeutic use; D011379:Prognosis; D011425:Propionibacterium acnes / Q000276:immunology
D001500:BCG Vaccine; D007370:Interferon Type I; D008222:Lymphokines; D007978:Levamisole; D002330:Carmustine